Literature DB >> 16511588

Estrogen receptors and human disease.

Bonnie J Deroo1, Kenneth S Korach.   

Abstract

Estrogens influence many physiological processes in mammals, including but not limited to reproduction, cardiovascular health, bone integrity, cognition, and behavior. Given this widespread role for estrogen in human physiology, it is not surprising that estrogen is also implicated in the development or progression of numerous diseases, which include but are not limited to various types of cancer (breast, ovarian, colorectal, prostate, endometrial), osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, lupus erythematosus, endometriosis, and obesity. In many of these diseases, estrogen mediates its effects through the estrogen receptor (ER), which serves as the basis for many therapeutic interventions. This Review will describe diseases in which estrogen, through the ER, plays a role in the development or severity of disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511588      PMCID: PMC2373424          DOI: 10.1172/JCI27987

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  123 in total

1.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.

Authors:  N A Sims; S Dupont; A Krust; P Clement-Lacroix; D Minet; M Resche-Rigon; M Gaillard-Kelly; R Baron
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

2.  ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins.

Authors:  S Denger; G Reid; M Kos; G Flouriot; D Parsch; H Brand; K S Korach; V Sonntag-Buck; F Gannon
Journal:  Mol Endocrinol       Date:  2001-12

Review 3.  Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice.

Authors:  S O Mueller; K S Korach
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

4.  Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

Authors:  G Risbridger; H Wang; P Young; T Kurita; Y Z Wang; D Lubahn; J A Gustafsson; G Cunha; Y Z Wong
Journal:  Dev Biol       Date:  2001-01-15       Impact factor: 3.582

5.  Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.

Authors:  K Yoshidome; M A Shibata; C Couldrey; K S Korach; J E Green
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

6.  Localization of estrogen receptor beta protein expression in adult human bone.

Authors:  I P Braidman; L Hainey; G Batra; P L Selby; P T Saunders; J A Hoyland
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

Review 7.  Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial.

Authors:  L Mosca
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

8.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.

Authors:  S S Petanceska; V Nagy; D Frail; S Gandy
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

9.  Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

Authors:  M Campbell-Thompson; I J Lynch; B Bhardwaj
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

10.  Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure.

Authors:  S Ogawa; M Emi; M Shiraki; T Hosoi; Y Ouchi; S Inoue
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

View more
  435 in total

1.  Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.

Authors:  Jason M Held; David J Britton; Gary K Scott; Elbert L Lee; Birgit Schilling; Michael A Baldwin; Bradford W Gibson; Christopher C Benz
Journal:  Mol Cancer Res       Date:  2012-06-05       Impact factor: 5.852

Review 2.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

Review 3.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

Review 4.  Sex hormones and pain: the evidence from functional imaging.

Authors:  Katy Vincent; Irene Tracey
Journal:  Curr Pain Headache Rep       Date:  2010-10

5.  The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Authors:  Archana Dhasarathy; Masahiro Kajita; Paul A Wade
Journal:  Mol Endocrinol       Date:  2007-08-30

6.  Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues.

Authors:  Zejun Zhou; Lumin Zhang; Miao Ding; Zhenwu Luo; Shao Yuan; Meena B Bansal; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2017-09-01       Impact factor: 3.969

7.  Prospective cohort study of soy food intake and colorectal cancer risk in women.

Authors:  Gong Yang; Xiao-Ou Shu; Honglan Li; Wong-Ho Chow; Hui Cai; Xianglan Zhang; Yu-Tang Gao; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

8.  Familial Multiplicity of Estrogen Insensitivity Associated With a Loss-of-Function ESR1 Mutation.

Authors:  Valérie Bernard; Sakina Kherra; Bruno Francou; Jérôme Fagart; Say Viengchareun; Jérôme Guéchot; Asmahane Ladjouze; Anne Guiochon-Mantel; Kenneth S Korach; Nadine Binart; Marc Lombès; Sophie Christin-Maitre
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

9.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

10.  Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.

Authors:  Nandita Das; Richard N Baumgartner; Elizabeth C Riley; Christina M Pinkston; Dongyan Yang; Kathy B Baumgartner
Journal:  J Cancer Surviv       Date:  2015-04-26       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.